Page 1522 - Cote clinical veterinary advisor dogs and cats 4th
P. 1522

772   Perianal Fistula


           •  Perianal licking/chewing        Acute General Treatment            Drug Interactions
           •  Scooting                        •  Cyclosporine 2-5 mg/kg PO q 12h until no   Interaction of cyclosporine with many drugs
  VetBooks.ir  •  Constipation/obstipation      ○   Preferred drug given reported high   concentrations; consult a formulary before
                                                                                 can increase or decrease blood  cyclosporine
                                                evidence of lesions
           •  Painful defecation
                                                  response rates
                                                                                 giving with other drugs.
           •  Foul odor and exudate
           •  Large-bowel diarrhea (if colitis)
                                                  administration can reduce cyclosporine
           •  Tenesmus                          ○   Ketoconazole  10 mg/kg  PO  q  24h   Possible Complications
           •  Hematochezia                        dosage to as low as 1 mg/kg PO q 12h   •  If lesions recur with drug dose reductions,
           •  Increased frequency of defecation   and thereby reduce treatment cost.  resume high-dose treatment.
           •  Ribbon-like stool                 ○   Microemulsified forms offer more con-  •  Surgical complications (recurrence, stricture,
                                                  sistent and predictable gastrointestinal   incontinence)
           PHYSICAL EXAM FINDINGS                 absorption.                    •  Constipation, obstipation, or anorectal stric-
           •  Pain when tail is lifted        •  Tacrolimus 0.1% ointment applied topically   tures may be managed with stool softeners.
           •  Epithelial  ulcerations  adjacent  to  or  sur-  to affected tissues q 12-24h is also associated   •  Azathioprine can cause hepatopathy, or bone
            rounding the anal opening, potentially with   with high response rates.  marrow suppression that usually manifests
            fistulous tracts extending into the deeper   ○   May be given in conjunction with   as thrombocytopenia or neutropenia in
            underlying tissue                     prednisone                       dogs.
           •  Purulent perianal discharge       ○   For dogs initially too painful for topical
           •  Foul odor                           application, may implement after improve-  Recommended Monitoring
           •  Thickened  or  ruptured  anal  sacs  or  rectal   ment is achieved with cyclosporine  Physical exam at intervals to document
            stricture possible                •  Prednisone  2 mg/kg  PO  q  24h  until  no   resolution or persistence of lesions is typically
                                                evidence of lesions, then tapered to lowest   sufficient. Improvement in many dogs is appre-
           Etiology and Pathophysiology         effective dose                   ciated within 2-4 weeks of starting cyclosporine.
           The underlying pathophysiology has not been   •  Azathioprine  1-2 mg/kg  PO  q  24h  until   •  Therapeutic  monitoring  of  cyclosporine
           determined. Improvement with immunosup-  lesions improve, then q 48h; often given in   can be considered, especially for dogs not
           pressive therapy and/or diet modifications   conjunction with prednisone  improving in response to treatment.
           incriminates a pathologic immune response   •  The benefits of the immunosuppressive drugs   ○   Trough  drug  concentrations  are  often
           to bacterial and/or dietary antigens.  mycophenolate mofetil or leflunomide have   suggested, but the analyzing laboratory
                                                not been explored.                   should be consulted for the timing
            DIAGNOSIS                         •  Cleaning  of  perineum  (under  sedation  or   of sample collection and target drug
                                                anesthesia) may be needed for some dogs.  concentration because results and recom-
           Diagnostic Overview                •  Analgesics                          mendations can vary with assays and drug
           Diagnosis is usually made by observing   •  Antibiotics (e.g., cephalexin 22 mg/kg PO   formulations.
           characteristic perianal lesions during physical   q 8h, metronidazole 10 mg/kg PO q 12h   ○   Pharmacodynamic monitoring based on
           examination of a dog with compatible history   for 14 days) are commonly given before or   suppression of T-lymphocyte function has
           and clinical signs.                  in conjunction with immunosuppressive   been  available  through  the  Mississippi
                                                therapy, but their role in disease manage-  State University College of  Veterinary
           Differential Diagnosis               ment has not been critically evaluated.   Medicine (http://www.cvm.msstate.edu/
           •  Anal sac neoplasia (primarily adenocarcinoma)  Because  antibiotics  alone  rarely  resolved,   animal-health-center/pharmacodynamic-
           •  Anal sacculitis or anal sac abscess  or minimally improved, lesions in the cases   laboratory).
           •  Chronic colitis of many causes (e.g., antibi-  described in the literature, their value has to    •  For dogs administered azathioprine
            otic responsive, diet responsive, infectious)  be questioned.          ○   Liver enzymes: weekly for the first month
           •  Colonic neoplasia                                                      (hepatopathy uncommon after 4 weeks)
                                              Chronic Treatment                    ○   CBC: weekly for the first 6-8 weeks, then
           Initial Database                   •  Some dogs require maintenance immunosup-  monthly
           Results of CBC, biochemical profile, and   pressive therapy to maintain remission.
           urinalysis are usually normal/unremarkable.  •  Anal sacculectomy may benefit a population    PROGNOSIS & OUTCOME
                                                of dogs that respond incompletely to medical
           Advanced or Confirmatory Testing     therapy, those that have anal sac involve-  Prognosis for most dogs is fair to good. Anal
           Colonoscopic biopsies, if obtained, can show   ment, or those with recurrence in the face   sac involvement may decrease the likelihood
           lymphocytic/plasmacytic  mucosal  infiltrates   of diminishing doses of immunosuppressive   of durable control with medical therapy alone.
           characteristic of colitis of many causes.  drugs.
                                              •  Some dogs may need surgical resection of    PEARLS & CONSIDERATIONS
            TREATMENT                           residual inflamed tissue.
                                              •  Some  of  the  literature  supports  a  period   Comments
           Treatment Overview                   of initial medical therapy to improve   Tapering immunosuppressive drugs to the
           A best treatment for this disease is not estab-  lesions before surgery with the goal of   lowest effective dose or longest dosing interval
           lished. Resolution of inflammation and associ-  reducing the amount of tissue to surgically     to control lesions is encouraged. Transition to
           ated clinical signs has been accomplished with   remove.              topical tacrolimus often reduces treatment
           medical therapy (immunosuppressive drugs,                             costs, especially for dogs needing long-term
           diet modification), surgery, or combinations   Nutrition/Diet         treatment.
           of the two. The role of surgery in the early   Feeding a novel protein/novel carbohydrate
           management has diminished given the responses   or hydrolyzed protein is often advocated with   Prevention
           typically expected with medical therapy, but   the potential of allowing immunosuppressive   There is no means of preventing this disease.
           surgery may play a role for some dogs (see   drugs to be given at low dosages, long dosing   Given the genetic predisposition of German
           Chronic Treatment below). Some have argued   intervals, intermittently (tacrolimus), or not at   shepherds, affected dogs should not be bred.
           that surgery can reduce the long-term expense   all. These diets can benefit dogs with concurrent     This  may  be  true  of  affected  dogs  of  other
           of medical treatment.              colitis.                           breeds.

                                                     www.ExpertConsult.com
   1517   1518   1519   1520   1521   1522   1523   1524   1525   1526   1527